403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Ventripoint Diagnostics Ltd
(MENAFN- Baystreet) 08:40 PM EST - Ventripoint Diagnostics Ltd: Announces it has received approval from the TSX Venture Exchange and issued of 601,115 common shares for the payment of an aggregate of $72,143 of interest owing on certain outstanding Convertible Debentures issued by the Corporation on May 10, 2024, June 28, 2024 and December 16, 2024. The Convertible Debentures bear interest at the rate of 10% per annum, payable every 6 months. The Shares will be issued at a deemed price of ($0.12), subject to the approval of TSXV, and are subject to a hold period of 4 months and one day. Ventripoint Diagnostics Ltd
shares V are trading unchanged at $0.09.
Full Press Release:
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment